| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
Aspire Biopharma Holdings, Inc.
13G/A
ASBP · 738920305
|
7.9% |
8/6/2026
Event 8/4/2026
|
||||
|
Aspire Biopharma Holdings, Inc.
13G/A
ASBP · 738920107
|
4.5% |
5/19/2025
Event 5/6/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.